PhysQuiz: A Focus on Tardive dyskinesia
Are you caught up on what’s happening on advancements in managing tardive dyskinesia? Test...
CID1735
A Focus on Tardive Dsykinesia – eBook
Focus on Tardive Dyskinesiav2.indd Featuring Q&A with Dr. McEvoy and Dr. Meyer on Tardive...
The Challenges in Treating TD: Underdiagnosed & Unrecognized
Jonathan Meyer, MD Clinical Professor of Psychiatry University of California San Diego Chirag...
The Role of VMAT2 Inhibitors in Managing TD During Schizophrenia Treatment
Chirag Shah, PharmD, RPh Head Medical Affairs & Medical Education Neurocrine Biosciences...
Identifying Patients with Tardive Dyskinesia
Jonathan Meyer, MD Clinical Professor of Psychiatry University of California San Diego ...
PhysQuiz Answers! A Focus on Tardive Dyskinesia
Thank you for taking our medical quiz on Tardive Dyskinesia! How did you do? According to an interview with Jonathan Meyer, MD, Clinical Professor of Psychiatry at UCSD, risk factors for developing tardive dyskinesia do...
Q&A with Dr. McEvoy and Dr. Meyer on Tardive Dyskinesia
Physician’s Weekly interviews Joseph McEvoy, MD, Professor Emeritus of Psychiatry and...
New Poll: Patients Confident in Telepsychiatry
Many Americans have used telehealth and would turn to it for mental health care, a new online poll...
Effect of DRD2 and COMT on Tardive Dyskinesia and Cognition in Schizophrenia
The aim of the study is to test the association of a functional variant each in DRD2 and COMT genes with schizophrenia and its endophenotypes. Effect of two functional variants rs1076560 in DRD2 and rs4680 in COMT on (1)...
